David Escobar

447 total citations
25 papers, 299 citations indexed

About

David Escobar is a scholar working on Molecular Biology, Oncology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, David Escobar has authored 25 papers receiving a total of 299 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 9 papers in Oncology and 8 papers in Pulmonary and Respiratory Medicine. Recurrent topics in David Escobar's work include Cancer Immunotherapy and Biomarkers (4 papers), IgG4-Related and Inflammatory Diseases (2 papers) and Marine Ecology and Invasive Species (2 papers). David Escobar is often cited by papers focused on Cancer Immunotherapy and Biomarkers (4 papers), IgG4-Related and Inflammatory Diseases (2 papers) and Marine Ecology and Invasive Species (2 papers). David Escobar collaborates with scholars based in United States, China and Canada. David Escobar's co-authors include Joel M. Stary, David J. Forsthoefel, Ana Paula Vieira, Phillip A. Newmark, Tao‐Lan Zhang, Guohua Lv, Ming‐Xiang Zou, Guang‐Yu Yang, Lingxiang Jiang and Jianming Ye and has published in prestigious journals such as Journal of Clinical Investigation, SHILAP Revista de lepidopterología and Development.

In The Last Decade

David Escobar

22 papers receiving 296 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
David Escobar United States 8 158 80 60 50 47 25 299
Chris Showell United States 8 304 1.9× 20 0.3× 20 0.3× 31 0.6× 50 1.1× 10 385
Cornelia von Levetzow Germany 6 271 1.7× 16 0.2× 35 0.6× 15 0.3× 113 2.4× 7 368
Jialiang S. Wang United States 8 201 1.3× 10 0.1× 43 0.7× 29 0.6× 9 0.2× 12 306
Lacey Ellington United States 4 279 1.8× 20 0.3× 63 1.1× 8 0.2× 16 0.3× 5 383
M. Stark United Kingdom 7 157 1.0× 17 0.2× 78 1.3× 7 0.1× 78 1.7× 9 386
H. Anne F. Booth United Kingdom 3 353 2.2× 21 0.3× 52 0.9× 6 0.1× 16 0.3× 3 458
Isabelle Guisle‐Marsollier France 7 150 0.9× 11 0.1× 89 1.5× 33 0.7× 51 1.1× 7 325
Stefan van der Elst Netherlands 6 478 3.0× 29 0.4× 111 1.9× 5 0.1× 21 0.4× 7 612
Alan Y. Wong United States 6 170 1.1× 20 0.3× 12 0.2× 9 0.2× 8 0.2× 6 239
Joey Riepsaame United Kingdom 9 316 2.0× 17 0.2× 16 0.3× 4 0.1× 19 0.4× 11 392

Countries citing papers authored by David Escobar

Since Specialization
Citations

This map shows the geographic impact of David Escobar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Escobar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Escobar more than expected).

Fields of papers citing papers by David Escobar

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David Escobar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Escobar. The network helps show where David Escobar may publish in the future.

Co-authorship network of co-authors of David Escobar

This figure shows the co-authorship network connecting the top 25 collaborators of David Escobar. A scholar is included among the top collaborators of David Escobar based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David Escobar. David Escobar is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Potluri, Tanvi, Ping Yin, John S. Coon, et al.. (2025). Estrogen receptor-α ablation reverses muscle fibrosis and inguinal hernias. Journal of Clinical Investigation. 135(6). 1 indexed citations
2.
Zou, Ming‐Xiang, Pengfei Wu, Haihong Hu, et al.. (2024). Is Type 2 Diabetes Mellitus Associated with Spinal Degenerative Disorders?. Journal of Bone and Joint Surgery. 106(13). 1189–1196. 1 indexed citations
3.
Vendrami, Camila Lopes, Amir A. Borhani, Pardeep Mittal, et al.. (2024). Imaging of Biliary Tree Abnormalities. Radiographics. 44(8). e230174–e230174. 5 indexed citations
4.
Choy, Bonnie, David Escobar, Ritu Nayar, et al.. (2024). Entrustable professional activities (EPAs) in surgical pathology: implementation experience and longitudinal observations of resident development. Academic Pathology. 11(4). 100150–100150.
5.
Zhang, Tao‐Lan, Xianpeng Huang, Lingxiang Jiang, et al.. (2024). Single-cell RNA sequencing reveals the MIF/ACKR3 receptor-ligand interaction between neutrophils and nucleus pulposus cells in intervertebral disc degeneration. Translational research. 272. 1–18. 13 indexed citations
6.
Vendrami, Camila Lopes, Nancy A. Hammond, David Escobar, et al.. (2024). Imaging of pancreatic serous cystadenoma and common imitators. Abdominal Radiology. 49(10). 3666–3685. 1 indexed citations
7.
Hu, Haihong, Ting Yan, Hongxia Zhu, et al.. (2023). A novel immune checkpoint-related signature for prognosis and immune analysis in breast cancer. Clinical and Experimental Medicine. 23(8). 5139–5159.
8.
Hu, Haihong, Ming‐Xiang Zou, Hongjuan Hu, et al.. (2023). A breast cancer classification and immune landscape analysis based on cancer stem-cell-related risk panel. npj Precision Oncology. 7(1). 130–130. 7 indexed citations
9.
Jia, Dan, Margaret Schwartz, Mary F. Mulcahy, et al.. (2023). HER2+ esophageal carcinoma leptomeningeal metastases treated with intrathecal trastuzumab regimen. CNS Oncology. 12(3). CNS99–CNS99. 2 indexed citations
10.
Zhang, Tao‐Lan, Hongxia Zhu, Hongjuan Hu, et al.. (2023). Cardiovascular-specific mortality and risk factors in colorectal Cancer patients: A cohort study based on registry data of over 500,000 individuals in the US. Preventive Medicine. 179. 107796–107796. 5 indexed citations
11.
Escobar, David, et al.. (2023). High-Density IgG4+ Plasma Cells Infiltration Is Associated With Fibroplasia in Fibrostenotic Crohn's Disease. International Journal of Surgical Pathology. 31(6). 1085–1092. 2 indexed citations
12.
Escobar, David, et al.. (2022). The Possible Pathogenic Role of IgG4-Producing Plasmablasts in Stricturing Crohn’s Disease. Pathobiology. 89(4). 187–197. 6 indexed citations
13.
Vendrami, Camila Lopes, Linda C. Kelahan, David Escobar, et al.. (2022). Imaging Findings of Eosinophilic Gastrointestinal Diseases in Adults. Current Problems in Diagnostic Radiology. 52(2). 139–147. 7 indexed citations
14.
Finkelman, Brian S., et al.. (2022). Overexpression of programmed death ligand 1 in refractory inflammatory bowel disease. Human Pathology. 126. 19–27. 7 indexed citations
15.
16.
17.
Escobar, David, Ridhdhi Desai, Noboru Ishiyama, et al.. (2015). α-catenin phosphorylation promotes intercellular adhesion through a dual-kinase mechanism. Journal of Cell Science. 128(6). 1150–65. 37 indexed citations
18.
Furfine, Eric S., et al.. (2013). Preclinical Development of EBI-005: a Potent Interleukin-1 (IL-1) Receptor-1 (R1) Blocker for Topical Ocular Administration was Safe in GLP Toxicology Studies and Active in a Mouse Model of Dry Eye Disease (DED). Investigative Ophthalmology & Visual Science. 54(15). 4320–4320. 2 indexed citations
19.
Forsthoefel, David J., et al.. (2012). An RNAi Screen Reveals Intestinal Regulators of Branching Morphogenesis, Differentiation, and Stem Cell Proliferation in Planarians. Developmental Cell. 23(4). 691–704. 105 indexed citations
20.
Forsthoefel, David J., David Escobar, Joel M. Stary, & Phillip A. Newmark. (2008). Intestinal renewal and regeneration in the planarian Schmidtea mediterranea. Developmental Biology. 319(2). 559–559. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Chris Showell Breakdown of academic impact, for papers by Cornelia von Levetzow Breakdown of academic impact, for papers by Jialiang S. Wang Breakdown of academic impact, for papers by Lacey Ellington Breakdown of academic impact, for papers by M. Stark Breakdown of academic impact, for papers by H. Anne F. Booth Breakdown of academic impact, for papers by Isabelle Guisle‐Marsollier Breakdown of academic impact, for papers by Stefan van der Elst Breakdown of academic impact, for papers by Alan Y. Wong Breakdown of academic impact, for papers by Joey Riepsaame
Rankless by CCL
2026